Bristol-Myers Squibb Company
MACROCYCLIC TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS
Last updated:
Abstract:
Compounds having a structure according to formula are modulators of TLR7 activity and can be used to treat conditions amenable to treatment by the modulation of TLR7 activity. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
23 Apr 2019
Issue date:
25 Feb 2021